BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Sanofi-Aventis K.K. 

Tokyo Opera City Tower
20-2, Nishishinjuku 3-chome, Shinjuku-ku
Tokyo    163-1488  Japan
Phone: 81-3-6301-3000 Fax: 81-3-6301-4007


SEARCH JOBS










 Company News
Former Sanofi-Aventis K.K. and US Oncology Executive Joins New Century Health as Chief Executive Officer 1/17/2012 7:21:49 AM    More...
As Deadline Nears, Suitor Genzyme Corporation (GENZ) May Have to Revise Bid For Sanofi-Aventis K.K. 12/10/2010 8:15:47 AM    More...
Zealand Pharma Announces An Extension Of The Lixisenatide Global Licensing Agreement With Sanofi-Aventis K.K. For Type-2 Diabetes 6/8/2010 10:12:22 AM    More...
Sanofi-Aventis K.K., Massachusetts Life Sciences Center to Announce New Investment Partnership at Biotechnology Industry Organization (BIO) 2010 5/5/2010 10:22:00 AM    More...
Sanofi-Aventis K.K., Massachusetts Life Sciences Center to Announce New Investment Partnership at Biotechnology Industry Organization (BIO) 2010 5/4/2010 11:35:54 AM    More...
Traversa Therapeutics, Inc. and Sanofi-Aventis K.K. Enter into a Research Agreement for the Development of Traversa's RNAi Delivery Technology 3/25/2010 10:30:31 AM    More...
Sanofi-Aventis K.K. And Bristol-Myers Squibb Company (BMY) Announce Important Updates to PLAVIX U.S. Prescribing Information; FDA Announces New Boxed Warning on Plavix 3/12/2010 12:27:57 PM    More...
Sanofi-Aventis K.K. Video Q&A : CEO Chris Viehbacher Comments on 2009 Full-Year Earnings 2/10/2010 10:17:24 AM    More...
Aspirin Without Bristol-Myers Squibb Company (BMY) And Sanofi-Aventis K.K.'s Plavix As Good After Heart Bypass, CASCADE Study 11/17/2009 7:03:53 AM    More...
Sanofi-Aventis K.K. And Bristol-Myers Squibb Company (BMY)'s Plavix Works In Men And Women, With Differences, New York University Study 11/10/2009 6:45:20 AM    More...
123